A case of splenic artery aneurysm and rupture in a patient on a vascular endothelial growth factor inhibitor for renal cell carcinoma-Reference-Cited by-同舟云学术

A case of splenic artery aneurysm and rupture in a patient on a vascular endothelial growth factor inhibitor for renal cell carcinoma

Published:2021-10-28 Issue: Volume: Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Tesolin Daniel¹^ORCID,Alaref Amer¹²,Ibrahim Mohammed F. K.¹³

Affiliation:

1. Northern Ontario School of Medicine Lakehead University Thunder Bay Ontario P3E 2C6 Canada

2. Diagnostic Imaging Department Thunder Bay Regional Health Sciences Centre Thunder Bay Ontario P7B 6V4 Canada

3. Regional Cancer Care Northwest Thunder Bay Regional Health Sciences Centre Thunder Bay Ontario P7B 6V4 Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1567

Reference7 articles.

1. National Comprehensive Cancer Network.Kidney Cancer Version 4;2021.https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf. Accessed April 4 2021.

2. Effects of Cancer Therapy Targeting Vascular Endothelial Growth Factor Receptor on Central Blood Pressure and Cardiovascular System

3. Examining the bleeding incidences associated with targeted therapies used in metastatic renal cell carcinoma

4. The Impact of Pazopanib on the Cardiovascular System

5. Association Between Aortic Dissection and Systemic Exposure of Vascular Endothelial Growth Factor Pathway Inhibitors in the Japanese Adverse Drug Event Report Database

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endovascular and Open Surgical Treatment of Ruptured Splenic Artery Aneurysms: A Case Report and a Systematic Literature Review;Journal of Clinical Medicine;2023-09-20

2. Pazopanib/sunitinib;Reactions Weekly;2022-09-03